ArticleEuropean geriatric medicine2026
Scientific highlights and perspectives from Early-Career Geriatricians: insights from the 21st EuGMS Congress, Reykjavik 2025.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo synthesise the principal scientific advances and professional development opportunities presented at the 21st EuGMS Congress, with a focus on findings likely to influence future geriatric practice and research priorities.
methodsMembers of the EuGMS-Early-Career Geriatricians Initiative (ECGI) attended and reviewed congress sessions, including all plenary lectures, joint symposia with major European and international societies, ECGI-organised sessions, and selected Special Interest Group (SIG) meetings. A narrative, non-systematic synthesis was developed through collaborative discussion, guided by the congress theme of 'New Landscapes in Geriatric Medicine' and informed by on-demand access to recorded sessions.
resultsKey scientific contributions included advances in the management of multimorbidity, hypertension, osteoporosis, nutrition-related disorders, frailty, and sarcopenia. Emerging trial and cohort data emphasised the importance of refined assessment tools and improved risk stratification to support individualised care. Sessions consistently highlighted the value of multidisciplinary models integrating geriatrics with cardiology, endocrinology, oncology, and surgical care. Congress activities also facilitated research capacity-building through peer exchange, SIG engagement, and structured early-career initiatives, supporting methodological skill development and fostering cross-national collaborations.
conclusionThe scientific advances marked a pivotal moment for geriatric medicine in Europe, with biological diagnostics, personalised treatment strategies, and cross-specialty collaboration rapidly reshaping comprehensive care for older people. Translating these advances equitably will require sustained investment in geriatric workforce development and research infrastructure and represents a call to align health policy with the growing complexity of an ageing population.
Indexed as
Identifiers
42474659What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.